The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Patients with chronic kidney disease (CKD) have a significantly higher risk of developing cardiovascular disease (CVD).
• CKD presence worsens CVD prognosis, increasing morbidity and mortality.
• Therapeutic options for CVD in advanced CKD are often limited and poorly studied.

Purpose of the Study:

• To summarize the epidemiology and clinical presentation of CVD in CKD patients.
• To review current treatment options for CVD manifestations in this high-risk population.
• To discuss strategies for reducing morbidity and mortality in CKD patients with CVD.

Main Methods:

• Literature review and synthesis of existing studies.
• Analysis of epidemiological data on CKD and CVD co-occurrence.
• Evaluation of current therapeutic guidelines and clinical trial outcomes.

Main Results:

• CKD is a major risk factor for coronary artery disease, heart failure, arrhythmias, and sudden cardiac death.
• Advanced CKD often excludes patients from major cardiovascular outcome trials, limiting evidence-based treatment.
• Treatment strategies frequently rely on extrapolation from studies on patients without CKD.

Conclusions:

• CKD and CVD represent a dangerous comorbidity with high mortality rates.
• There is a critical need for better-understood and tailored treatment strategies for CVD in CKD.
• Further research and clinical trials are essential to improve outcomes for this vulnerable patient group.